Total investments received (USD): 8m
Round value (USD): 8m
Round investors:
Acorn Bioventures
Seamus Mulligan
Company: ONK Therapeutics
Industry:
Biotech
Health services



Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Italy
Portugal
Spain